Sutro Biopharma Cash from Financing (Quarterly) Analysis

Sutro Biopharma Inc (STRO)

3.995 -0.16 (-3.73%) USD | NASDAQ | May 17, 16:00

3.995 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	-3.429M
December 31, 2023	-3.125M
September 30, 2023	-5.74M
June 30, 2023	137.66M
March 31, 2023	8.758M
December 31, 2022	12.22M
September 30, 2022	29.85M
June 30, 2022	5.485M
March 31, 2022	0.76M
December 31, 2021	0.506M
September 30, 2021	0.963M
June 30, 2021	-0.039M
March 31, 2021	1.826M

Date	Value
December 31, 2020	144.85M
September 30, 2020	17.27M
June 30, 2020	91.42M
March 31, 2020	15.70M
December 31, 2019	-1.78M
September 30, 2019	-1.127M
June 30, 2019	-0.819M
March 31, 2019	-0.458M
December 31, 2018	87.86M
September 30, 2018	50.18M
June 30, 2018	32.77M
March 31, 2018	-0.014M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-5.74M

Minimum

Sep 2023

144.85M

Maximum

Dec 2020

22.56M

Average

1.394M

Median

Cash from Financing (Quarterly) Benchmarks

AnaptysBio Inc	-13.63M
ABVC BioPharma Inc	0.0874M
Reviva Pharmaceuticals Holdings Inc	0.332M
Flora Growth Corp	0.704M
Journey Medical Corp	1.637M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-64.74M
Cash from Investing (Quarterly)	64.10M
Free Cash Flow	-119.18M
Free Cash Flow Per Share (Quarterly)	-1.061
Free Cash Flow to Equity (Quarterly)	-61.13M
Free Cash Flow to Firm (Quarterly)	-59.89M
Free Cash Flow Yield	-48.85%